Lv11
60 积分 2025-04-11 加入
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
8小时前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
3个月前
已完结
Metabolites as agents and targets for cancer immunotherapy
3个月前
已完结
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
5个月前
已完结
皖公网安备34019202002308
